Repligen (RGEN) PT Lowered to $145 at Canaccord

April 20, 2026 7:37 AM

Canaccord analyst Kyle Mikson lowered the price target on Repligen (NASDAQ: RGEN) to $145.00 (from $165.00) while maintaining a Hold rating.

No results found